Universal-Beteiligungs- und Servicegesellschaft’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.35M Buy
115,125
+42,695
+59% +$2.05M 0.01% 914
2026
Q1
$3.74M Sell
72,430
-8,016
-10% -$408K 0.01% 999
2025
Q4
$4M Sell
80,446
-29,390
-27% -$1.43M 0.01% 983
2025
Q3
$5.25M Buy
109,836
+24,302
+28% +$979K 0.01% 850
2025
Q2
$2.7M Buy
85,534
+19,949
+30% +$639K ﹤0.01% 1076
2025
Q1
$2.15M Buy
+65,585
New +$2.32M ﹤0.01% 1162

Other funds holding SUPN

Universal-Beteiligungs- und Servicegesellschaft's SUPN Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Supernus Pharmaceuticals (SUPN) stake by 59% in Q2 2026, buying an estimated $2.05M and bringing the position to 115,125 shares worth $5.35M. The position accounts for 0.01% of the portfolio, ranked #914.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in SUPN in Q1 2025 and has held it in 6 quarters since. 216 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 115,125 shares of Supernus Pharmaceuticals worth $5.35M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 42,695 Supernus Pharmaceuticals shares in Q2 2026, an estimated $2.05M.
  • Supernus Pharmaceuticals made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #914 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Supernus Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 216 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.